Vaxxinity Inc
OTC:VAXX
Vaxxinity Inc
OTC:VAXX
Price:
0.0002
USD
100%
Market Cap:
$25.4k
Relative Value
There is not enough data to reliably calculate the relative value of VAXX.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VAXX
Relative Value
Base Case
Not Available
Multiples Across Competitors
VAXX Competitors Multiples
Vaxxinity Inc Competitors
Vaxxinity Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Vaxxinity Inc
OTC:VAXX
|
25.3k USD | 0 | -0 | 0.3 | 0.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
413.5B USD | 6.8 | 171.9 | 16.6 | 23.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
200.1B USD | 5.5 | 26.3 | 15 | 15 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
192.7B USD | 6.5 | 22.4 | 15.2 | 15.2 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.2B USD | 9.9 | 30.1 | 23 | 24 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.9B USD | 5.8 | 18.5 | 14.1 | 16.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
73.9B AUD | 3.3 | 17.1 | 11.7 | 14.6 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.3B EUR | 14.4 | 33.8 | 58.1 | 59.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
